In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

With more than 230,000 positive drug tests since 2020, how the trucking industry detects drivers’ drug use is an important topic. Currently, Department of Transportation drug testing relies entirely ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

FDA and NIH recently announced initiatives outlining specific actions each agency will take to encourage greater adoption of new and emerging technologies to reduce the need for — and potentially ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

For the reduction and eventual elimination of animal testing, change is in the air. And it could occur faster than many previously believed. It appears that more powerful voices are joining the choir.